TB-500
Thymosin Beta-4
Synthetic counterpart of thymosin β-4, studied in cell-migration models.
7 papers · 1985–2019 · 6 journals
What the research explores
Thymosin β-4 and its synthetic counterparts are studied for their role in cytoskeletal regulation, which places them across a wide span of preclinical repair literature.
Areas of investigation include:
- G-actin sequestration, and the assembly and disassembly of actin filaments
- Cell migration in culture, including endothelial and epithelial model systems
- Angiogenesis and vessel formation in animal models
- Dermal and corneal wound-model research
- Cardiac tissue models following experimental injury
All of the above is preclinical. The peptide is supplied for laboratory research and has no approved application in humans.
References
A reference list, not evidence. Inclusion means a paper discusses the compound — not that it supports any use, and not that it describes this product.
2019
- Tβ4-Ac-SDKP pathway: Any relevance for the cardiovascular system?
Kassem KM, Vaid S, Peng H, et al.
Canadian journal of physiology and pharmacology
- Tβ4-Ac-SDKP pathway: Any relevance for the cardiovascular system?
2018
- Thymosin beta 4 and the eye: the journey from bench to bedside
Sosne G
Expert opinion on biological therapy
- Thymosin beta 4 and the eye: the journey from bench to bedside
2016
- Thymosin β4 Promotes Dermal Healing
Kleinman HK, Sosne G
Vitamins and hormones
- Thymosin β4 Promotes Dermal Healing
2007
- beta-Thymosins
Hannappel E
Annals of the New York Academy of Sciences
- The beta-thymosin enigma
Sun HQ, Yin HL
Annals of the New York Academy of Sciences
- beta-Thymosins
2001
- Actin dynamics
Pollard TD, Blanchoin L, Mullins RD
Journal of cell science
- Actin dynamics
1985
- Thymosin beta 4
Low TL, Goldstein AL
Methods in enzymology
- Thymosin beta 4
For laboratory and research use only · Not for human or veterinary consumption · Not evaluated by the FDA
